CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
HIFU vs Cryoablationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06929065
NCT06929065N/ACompleted
CompareCT.gov

Randomized Prospective Trial of Focal Therapy (HIFU vs Cryo) for Early Stage Unifocal Prostate Cancer

Kaiser Permanente·interventional·Posted Apr 15, 2025·Updated Apr 15, 2025

In Brief

A clinical study evaluating HIFU vs Cryoablation for Prostate Cancer and 5 related conditions. Completed, enrolled 50 participants across 1 site.

Detailed Summary

HIFU has been FDA approved and is widely utilized across the United States and Europe for the treatment of prostate cancer. Despite this, HIFU has not been offered within SCPMG until now due to growing patient demand. We have offered cryoablation. This pilot study will determine the efficacy of HIFU vs. cryoablation focal therapy for early stage prostate cancer within SCPMG. We hope to elucidate whether outcomes are similar between the two modalities.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer, Prostate Cancer Stage I, Prostate Cancer Stage II, High Intensity Focused Ultrasound, HIFU, Cryoablation
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedApr 15, 2025
Enrollment StartApr 1, 2023
Primary CompletionFeb 1, 2025
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 1.2 years ago

Interventions

HIFU vs Cryoablationprocedure

HIFU vs cryoablation